Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16885 http://scihub22266oqcxt.onion/10.1111/bjh.16885 32453877!7283673!32453877     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Haematol 2020 ; 190 (2): 179-184 Nephropedia Template TP {{tp|p=32453877|t=2020. Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) |pdf=|usr=}}{{32453877}} gab.com Text Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32453877 #FOAvip Coronavirus disease 2019 (COVID-19) can affect the haematopoietic system. Thrombocytopenia at admission was prevalent, while late-phase or delayed-phase thrombocytopenia (occurred 14 days after symptom onset) is rare. This retrospective, single-centre study screened 450 COVID-19 patients and enrolled 271 patients at the Union Hospital, Wuhan, China, from January 25 to March 9, 2020. COVID-19-associated delayed-phase thrombocytopenia occurred in 11.8% of enrolling patients. The delayed-phase thrombocytopenia in COVID-19 is prone to develop in elderly patients or patients with low lymphocyte count on admission. The delayed-phase thrombocytopenia is significantly associated with increased length of hospital stay and higher mortality rate. Delayed-phase nadir platelet counts demonstrated a significantly negative correlation with B cell percentages. We also provided and described bone marrow aspiration pathology of three patients with delayed-phase thrombocytopenia, showing impaired maturation of megakaryocytes. We speculated that immune-mediated platelet destruction might account for the delayed-phase thrombocytopenia in a group of patients. In addition, clinicians need to pay attention to the delayed-phase thrombocytopenia especially at 3-4 weeks after symptom onset. Twit Text FOAVip Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32453877 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32453877 #FOAvip English Wikipedia <ref>{{Cite pmid|32453877}}</ref> Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) #MMPMID32453877 Chen W; Li Z; Yang B; Wang P; Zhou Q; Zhang Z; Zhu J; Chen X; Yang P; Zhou H Br J Haematol 2020[Jul]; 190 (2): 179-184 PMID32453877show ga Coronavirus disease 2019 (COVID-19) can affect the haematopoietic system. Thrombocytopenia at admission was prevalent, while late-phase or delayed-phase thrombocytopenia (occurred 14 days after symptom onset) is rare. This retrospective, single-centre study screened 450 COVID-19 patients and enrolled 271 patients at the Union Hospital, Wuhan, China, from January 25 to March 9, 2020. COVID-19-associated delayed-phase thrombocytopenia occurred in 11.8% of enrolling patients. The delayed-phase thrombocytopenia in COVID-19 is prone to develop in elderly patients or patients with low lymphocyte count on admission. The delayed-phase thrombocytopenia is significantly associated with increased length of hospital stay and higher mortality rate. Delayed-phase nadir platelet counts demonstrated a significantly negative correlation with B cell percentages. We also provided and described bone marrow aspiration pathology of three patients with delayed-phase thrombocytopenia, showing impaired maturation of megakaryocytes. We speculated that immune-mediated platelet destruction might account for the delayed-phase thrombocytopenia in a group of patients. In addition, clinicians need to pay attention to the delayed-phase thrombocytopenia especially at 3-4 weeks after symptom onset. |Adult[MESH] |Aged[MESH] |Betacoronavirus[MESH] |Bone Marrow/pathology[MESH] |COVID-19[MESH] |China[MESH] |Coronavirus Infections/*complications[MESH] |Female[MESH] |Humans[MESH] |Incidence[MESH] |Longitudinal Studies[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Platelet Count[MESH] |Pneumonia, Viral/*complications[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Delayed-phase thrombocytopenia in patients with coronavirus disease 20(epmc).pdf DeepDyve Pubget Overpricing